A double-blind, placebo-controlled trial of Zoloft's [sertraline] effects on symptoms and survival time in advanced cancer.

Trial Profile

A double-blind, placebo-controlled trial of Zoloft's [sertraline] effects on symptoms and survival time in advanced cancer.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 15 Jun 2016

At a glance

  • Drugs Sertraline (Primary)
  • Indications Cancer
  • Focus Adverse reactions
  • Acronyms ZEST
  • Most Recent Events

    • 08 Jul 2011 New source identified and integrated (Australian New Zealand Clinical Trials Registry).
    • 11 Aug 2009 Pfizer added as trial sponsor and additional trial location (Australia) identified ISRCTN: Current Controlled Trials record.
    • 13 Jul 2007 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top